RE:TFC-1067 / R&F What I take away from this analysis is that it could possibly be considered a proxy indicator of actual gross sales that Rodan had incurred over the past few years, based upon booked revenues for bulk product at $8K USD per kilogram - the line was no doubt nothing to scoff at even if we only got crumbs.
Time will tell, but safe to say that if and when they go to market, that these numbers can be used as a general baseline estimate in the absence of any information from the company, pathetic as that may be.
They said they sacrificed upfront for a higher royalty so I am guessing the higher end of the royalty range of 8-12%.
AbbVie is a better partner and royalties are the game we want to be positioned with.